Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STREAM
NCT02409290Phase 3Completed
- Sponsor
- International Union Against Tuberculosis and Lung Disease
- Start
- Mar 2016
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of bedaquiline in multidrug-resistant tuberculosis (MDR-TB), sponsored by International Union Against Tuberculosis and Lung Disease. Started Mar 2016; status: completed.
02
Drugs
bedaquiline
03
Conditions
multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on NCT02409290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409290.